Details of the Drug | DrugMAP

General Information of Drug (ID: DMG77O2)

Drug Name

Efavaleukin alfa

Synonyms

AMG592

Indication

Disease Entry	ICD 11	Status	REF
Systemic lupus erythematosus	4A40.0	Phase 2	[1]
Ulcerative colitis	DD71	Phase 2	[2]
------------------------------------------------------------------------------------

Drug Type

Fusion Protein

Cross-matching ID

UNII: YNH9K62UXU
DrugBank ID: DB16149
TTD ID: D1NDO8

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT04680637) A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus With Inadequate Response to Standard of Care Therapy. U.S.National Institutes of Health.
2	ClinicalTrials.gov (NCT04987307) A Phase 2, Dose-finding, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Efavaleukin Alfa Induction Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis. U.S.National Institutes of Health.